Skip to main content

Table 1 Characteristics of patients in the ALK-positive and ALK-negative groups

From: Clinicopathological and computed tomography features of patients with early-stage non-small-cell lung cancer harboring ALK rearrangement

Variables

ALK+ (n = 65)

ALK- (n = 629)

Χ2(t)

P-value

Age (years) Mean ± SD (range)

55.86 ± 9.41 (33–73)

58.55 ± 9.72 (23–81)

−2.133

0.033a

 ≥ 60 y

24 (36.9)

313 (49.8)

3.887

0.049

 < 60 y

41 (63.1)

316 (50.2)

3.887

0.049

Sex

  

0.024

0.876

 Male

29 (44.6)

287 (45.6)

  

 Female

36 (55.4)

342 (54.4)

  

Smoking

  

1.913

0.167

 Nonsmoker

13 (20.0)

176 (28.0)

  

 Smoker

52 (80.0)

452 (72.0)

  

Family history of lung cancer

8 (12.3)

87 (13.9)

0.119

0.730

 CEA level

  

4.009

0.050

 Normal (0–5 ng/mL)

1 (1.5)

54 (8.6)

  

 Abnormal (> 5 ng/mL)

64 (98.5)

575 (91.4)

  
  1. Unless otherwise indicated, data are shown as numbers with percentages in parentheses. aindicates significant difference
  2. Abbreviations: CEA Carcinoembryonic antigen